Syneron Medical Company Profile (NASDAQ:ELOS)

About Syneron Medical (NASDAQ:ELOS)

Syneron Medical logoSyneron Medical Ltd. is engaged in the manufacture, research, development, marketing and sale of equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company's aesthetic medical products are based on its various technologies, including Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments. The Company's products target a range of non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, tattoo removal, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, and laser-assisted lipolysis.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Equipment, Supplies & Distribution
  • Sub-Industry: N/A
  • Symbol: NASDAQ:ELOS
  • CUSIP: N/A
  • Web: syneron-candela.com
Average Prices:
  • 50 Day Moving Avg: $10.90
  • 200 Day Moving Avg: $10.14
  • 52 Week Range: $6.18 - $11.43
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 21.15
  • P/E Growth: 0.00
Profitability:
  • Net Margins: -1.09%
  • Return on Equity: -1.74%
  • Return on Assets: -1.30%
Debt:
  • Current Ratio: 2.68%
  • Quick Ratio: 1.84%
Misc:
  • Average Volume: 797,289 shs.
  • Beta: 1.25
 

Frequently Asked Questions for Syneron Medical (NASDAQ:ELOS)

What is Syneron Medical's stock symbol?

Syneron Medical trades on the NASDAQ under the ticker symbol "ELOS."

How were Syneron Medical's earnings last quarter?

Syneron Medical Ltd. (NASDAQ:ELOS) posted its quarterly earnings results on Thursday, August, 4th. The company reported $0.09 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.03. The business earned $75 million during the quarter, compared to the consensus estimate of $75.72 million. Syneron Medical had a negative net margin of 1.09% and a negative return on equity of 1.74%. The firm's revenue for the quarter was up 2.0% on a year-over-year basis. During the same period in the previous year, the firm posted $0.07 earnings per share. View Syneron Medical's Earnings History.

Where is Syneron Medical's stock going? Where will Syneron Medical's stock price be in 2017?

2 brokers have issued 1-year target prices for Syneron Medical's stock. Their predictions range from $11.00 to $11.00. On average, they expect Syneron Medical's share price to reach $11.00 in the next twelve months. View Analyst Ratings for Syneron Medical.

Who are some of Syneron Medical's key competitors?

Who are Syneron Medical's key executives?

Syneron Medical's management team includes the folowing people:

  • Shimon Eckhouse Ph.D., Chairman of the Board
  • Amit Meridor, Chief Executive Officer
  • Hugo Goldman, Chief Financial Officer
  • Erik Dowell, Vice President-North America
  • William Griffing, Chief Executive Officer - Syneron Candela North America
  • Shlomo Alkalay, Chief Operating Officer
  • Lisa A. Soderquist, Chief Human Resource Officer
  • Robert Ruck, Executive Vice President, Asia Pacific
  • Robert Fielitz, Vice President and Managing Director of Europe, Middle East and Africa
  • Sarit Soccary Ben-Yochanan, Vice President - Business Development & Strategy

How do I buy Syneron Medical stock?

Shares of Syneron Medical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Syneron Medical's stock price today?

One share of Syneron Medical stock can currently be purchased for approximately $11.00.


MarketBeat Community Rating for Syneron Medical (NASDAQ ELOS)
Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  139 (Vote Outperform)
Underperform Votes:  81 (Vote Underperform)
Total Votes:  220
MarketBeat's community ratings are surveys of what our community members think about Syneron Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Syneron Medical (NASDAQ:ELOS) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating, 1 Buy Rating
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $11.00 (0.00% downside)
Consensus Price Target History for Syneron Medical (NASDAQ:ELOS)
Price Target History for Syneron Medical (NASDAQ:ELOS)
Analysts' Ratings History for Syneron Medical (NASDAQ:ELOS)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/12/2017Maxim GroupDowngradeBuy -> Hold$12.00 -> $11.00MediumView Rating Details
10/24/2016Brean CapitalReiterated RatingBuyN/AView Rating Details
8/5/2016Leerink SwannDowngradeOutperform -> Market Perform$9.40 -> $7.80N/AView Rating Details
(Data available from 10/24/2015 forward)

Earnings

Earnings History for Syneron Medical (NASDAQ:ELOS)
Earnings by Quarter for Syneron Medical (NASDAQ:ELOS)
Earnings History by Quarter for Syneron Medical (NASDAQ ELOS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/15/2017Q416$0.03($0.03)$82.02 million$82.90 millionViewListenView Earnings Details
11/9/2016Q316($0.02)$0.02$68.08 million$71.50 millionViewListenView Earnings Details
8/4/2016Q216$0.06$0.09$75.72 million$75.00 millionViewListenView Earnings Details
5/19/2016Q116$0.01$0.04$64.38 million$68.70 millionViewListenView Earnings Details
2/22/2016Q415$0.07$0.07$75.56 million$78.90 millionViewListenView Earnings Details
11/11/2015Q315$0.03$0.03$66.60 million$62.10 millionViewListenView Earnings Details
8/4/2015Q215$0.06$0.04$70.93 million$73.50 millionViewN/AView Earnings Details
5/13/2015Q115$0.01$0.02$62.08 million$63.40 millionViewListenView Earnings Details
2/18/2015Q414$0.06$0.09$71.42 million$74.10 millionViewN/AView Earnings Details
11/12/2014Q314$0.03$0.03$58.32 million$60.30 millionViewN/AView Earnings Details
8/6/2014Q214$0.07$0.07$63.52 million$64.60 millionViewListenView Earnings Details
5/14/2014Q114$0.04$0.04$55.50 million$56.80 millionViewN/AView Earnings Details
2/20/2014Q413$0.08$0.11$65.70 million$64.30 millionViewListenView Earnings Details
11/13/2013Q313$0.01$0.04$62.06 million$62.70 millionViewListenView Earnings Details
8/14/2013Q2 2013$0.09$0.02$70.93 million$68.80 millionViewN/AView Earnings Details
5/22/2013Q1 2013$0.02$0.02$61.19 million$61.20 millionViewN/AView Earnings Details
2/12/2013Q4 2012$0.09$0.11$70.60 million$72.80 millionViewN/AView Earnings Details
11/7/2012Q312$0.04$0.03$65.51 million$60.13 millionViewN/AView Earnings Details
8/15/2012$0.04$0.05ViewN/AView Earnings Details
2/9/2012$0.04$0.03ViewN/AView Earnings Details
11/10/2011($0.09)($0.03)ViewN/AView Earnings Details
8/11/2011($0.02)($0.01)ViewN/AView Earnings Details
5/19/2011($0.04)$0.01ViewN/AView Earnings Details
2/16/2011($0.04)$0.24ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Syneron Medical (NASDAQ:ELOS)
Current Year EPS Consensus Estimate: $0.33 EPS
Next Year EPS Consensus Estimate: $0.52 EPS

Dividends

Dividend History for Syneron Medical (NASDAQ:ELOS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Syneron Medical (NASDAQ:ELOS)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Syneron Medical (NASDAQ:ELOS)
Latest Headlines for Syneron Medical (NASDAQ:ELOS)
Source:
Loading headlines, please wait.

Social

Chart

Syneron Medical (ELOS) Chart for Tuesday, October, 24, 2017

This page was last updated on 10/24/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.